22-37710252-A-T

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_001039141.3(TRIOBP):​c.115-175A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.539 in 152,230 control chromosomes in the GnomAD database, including 22,802 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.54 ( 22802 hom., cov: 35)

Consequence

TRIOBP
NM_001039141.3 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.419

Publications

8 publications found
Variant links:
Genes affected
TRIOBP (HGNC:17009): (TRIO and F-actin binding protein) This gene encodes a protein with an N-terminal pleckstrin homology domain and a C-terminal coiled-coil region. The protein interacts with trio, which is involved with neural tissue development and controlling actin cytoskeleton organization, cell motility and cell growth. The protein also associates with F-actin and stabilizes F-actin structures. Mutations in this gene have been associated with a form of autosomal recessive nonsyndromic deafness. Multiple alternatively spliced transcript variants that would encode different isoforms have been found for this gene, however some transcripts may be subject to nonsense-mediated decay (NMD). [provided by RefSeq, Nov 2008]
TRIOBP Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 28
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 22-37710252-A-T is Benign according to our data. Variant chr22-37710252-A-T is described in ClinVar as [Benign]. Clinvar id is 1261002.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.678 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TRIOBPNM_001039141.3 linkc.115-175A>T intron_variant Intron 3 of 23 ENST00000644935.1 NP_001034230.1 Q9H2D6-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TRIOBPENST00000644935.1 linkc.115-175A>T intron_variant Intron 3 of 23 NM_001039141.3 ENSP00000496394.1 Q9H2D6-1
ENSG00000100101ENST00000455236.4 linkn.*451-175A>T intron_variant Intron 9 of 12 5 ENSP00000477208.1 V9GYY5
TRIOBPENST00000492485.5 linkn.251-175A>T intron_variant Intron 2 of 4 1
TRIOBPENST00000344404.10 linkn.115-175A>T intron_variant Intron 2 of 21 2 ENSP00000340312.6 H7BXW4

Frequencies

GnomAD3 genomes
AF:
0.539
AC:
81948
AN:
152112
Hom.:
22798
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.397
Gnomad AMI
AF:
0.519
Gnomad AMR
AF:
0.596
Gnomad ASJ
AF:
0.467
Gnomad EAS
AF:
0.697
Gnomad SAS
AF:
0.501
Gnomad FIN
AF:
0.567
Gnomad MID
AF:
0.513
Gnomad NFE
AF:
0.603
Gnomad OTH
AF:
0.545
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.539
AC:
81992
AN:
152230
Hom.:
22802
Cov.:
35
AF XY:
0.537
AC XY:
39936
AN XY:
74424
show subpopulations
African (AFR)
AF:
0.396
AC:
16465
AN:
41552
American (AMR)
AF:
0.596
AC:
9120
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.467
AC:
1622
AN:
3470
East Asian (EAS)
AF:
0.697
AC:
3599
AN:
5164
South Asian (SAS)
AF:
0.501
AC:
2418
AN:
4830
European-Finnish (FIN)
AF:
0.567
AC:
6019
AN:
10612
Middle Eastern (MID)
AF:
0.527
AC:
154
AN:
292
European-Non Finnish (NFE)
AF:
0.603
AC:
40964
AN:
67990
Other (OTH)
AF:
0.548
AC:
1158
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1983
3965
5948
7930
9913
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
716
1432
2148
2864
3580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.565
Hom.:
3042
Bravo
AF:
0.538
Asia WGS
AF:
0.575
AC:
2000
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
4.6
DANN
Benign
0.80
PhyloP100
0.42
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4821691; hg19: chr22-38106259; API